Schedule 13G ownership disclosure
BioLineRx Ltd.
Security class unavailable · CUSIP: 09071M106
Event date: 2017-12-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,000,000
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-073254
- Form type
- SC 13G
- Filer
- BioLineRx Ltd.
- CIK
- CIK 1498403
- Filed
- Dec 14, 2017
- Reporting period
- Dec 14, 2017
- Description
- Schedule 13G beneficial ownership